Merck Net Worth 2006-2019 | MRK

Interactive chart of historical net worth (market cap) for Merck (MRK) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Merck net worth as of June 21, 2019 is $217.74B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $217.738B $42.294B
Merck & Co., Inc., a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through their prescription medicines, vaccines, biologic therapies and animal health products, they work with customers and operate the countries to deliver innovative health solutions. The Company also demonstrate their commitment to increasing access to health care through far-reaching policies, programs and partnerships. Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $377.257B 17.29
Pfizer (PFE) United States $242.802B 14.18
Novartis AG (NVS) Switzerland $213.652B 18.46
Novo Nordisk (NVO) Denmark $124.229B 20.67
AbbVie (ABBV) United States $116.463B 9.63
Eli Lilly (LLY) United States $112.121B 20.81
Sanofi (SNY) France $110.213B 13.59
AstraZeneca (AZN) United Kingdom $104.761B 12.06
GlaxoSmithKline (GSK) United Kingdom $99.894B 12.66
Bristol-Myers Squibb (BMY) United States $80.706B 11.92